-
1
-
Phenotypic Expression and Clinical Course of Hypertrophic Cardiomyopathy
-
37
-
Genetic Mutations that Remodel the Heart in Hypertrophic Cardiomyopathy
-
67
-
Genetic Basis and Genotype‐Phenotype Relationships in Familial Hypertrophic Cardiomyopathy
-
81
-
Historical Perspective, Mechanism, and Clinical Significance of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
-
95
-
Hypertrophic Cardiomyopathy with Latent (Provocable) Obstruction: Pathophysiology and Management
-
105
-
Pathophysiology and Clinical Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
-
121
-
Other Modes of Disability or Death Including Stroke, and Treatment Strategies, in Hypertrophic Cardiomyopathy
-
132
-
Disturbed Vascular Control in Hypertrophic Cardiomyopathy: Mechanisms and Clinical Significance
-
147
-
Clinical Significance of Diastolic Dysfunction and the Effect of Therapeutic Interventions
-
158
-
Value of Exercise Testing in Assessing Clinical State and Prognosis in Hypertrophic Cardiomyopathy
-
172
-
Pathophysiology and Significance of Myocardial Ischemia in Hypertrophic Cardiomyopathy
-
185
-
Hypertrophic Cardiomyopathy in Japan: Clinical, Morphologic and Genetic Expression
-
195
-
Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy
-
200
-
Pharmacologic Treatment of Symptomatic Hypertrophic Cardiomyopathy
-
220
-
Obstructive Hypertrophic Cardiomyopathy: Results of Septal Myectomy
-
236
-
United States Perspectives on the Role of Dual‐Chamber Pacing in Patients With Hypertrophic Cardiomyopathy
-
246
-
Dual‐Chamber Pacing for Hypertrophic Obstructive Cardiomyopathy
-
259
-
Alcohol Septal Ablation
-
279
-
Alcohol Septal Ablation in the Treatment of Hypertrophic Obstructive Cardiomyopathy: A Seven‐Year Experience
-
297
-
Role of Septal Ablation in a Surgical Center
-
307
-
Molecular and Clinical Tools for Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy
-
319
-
Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy: Extreme Left Ventricular Hyptertrophy as a New Indicator of Risk
-
327
-
Implantable Defibrillator for Prevention of Sudden Death in Hypertrophic Cardiomyopathy
-
345
-
Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and not so Benign Arrhythmias
-
367
-
The Athlete's Heart, ECG, and Differential Diagnosis with Hypertrophic Cardiomyopathy and Other Cardiomyopathies
-
382
-
Importance of Congenital Coronary Artery Anomalies
-
393
-
Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program
-
404
-
Cardiovascular Causes of Sudden Death, Preparticipation Screening, and Criteria for Disqualification in Young Athletes
-
432
-
Sudden Death Due to Chest Blows (Commotio Cordis)
-
448
-
Naturally Occurring Animal Models of Cardiovascular Disease Causing Premature Death
-
473
-
The Role of the Internet and Patient Support Groups for Those Living with Hypertrophic Cardiomyopathy
-
481
-
Afterword
-
487
-
Index
-
i
-
Frontmatter